Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

2026 data Public-data reference. official source

Acute Ischemic Stroke

Open-data reference.

27 US clinical trials · 12 currently recruiting

Active & Recent Trials

RECRUITING 1,000 participants

Brain, Blood And Clot or Tissue Registry And Collaboration

Justin Fraser

NCT03153683

RECRUITING Phase 2 740 participants

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

Corxel Pharmaceuticals

NCT06990867

RECRUITING Phase 3 514 participants

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Pharmazz

NCT05691244

RECRUITING Phase 4 500 participants

SUMMIT RISE Study of Acute Ischemic Stroke Patients

Route 92 Medical

NCT07436156

RECRUITING Phase 3 404 participants

Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

Mercy Health Ohio

NCT05611242

RECRUITING Phase 2 228 participants

Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

Basking Biosciences

NCT06226805

RECRUITING NA 170 participants

The Pivotal Study of RapidPulseTM Aspiration System

RapidPulse

NCT06029491

RECRUITING 150 participants

Blood Pressure Variability and Ischemic Stroke Outcome

Yale University

NCT05756257

RECRUITING Phase 2 120 participants

Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke

University of California, Los Angeles

NCT06440707

RECRUITING NA 120 participants

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)

LCMC Health

NCT06148285

RECRUITING Phase 2 66 participants

A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT

Lumosa Therapeutics Co.

NCT05198323

RECRUITING NA 65 participants

Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke

Washington University School of Medicine

NCT07404852

ACTIVE NOT RECRUITING Phase 2 680 participants

A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

Shionogi

NCT05953480

ACTIVE NOT RECRUITING NA 530 participants

EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)

Dr. Michael D Hill

NCT05151172

ACTIVE NOT RECRUITING NA 50 participants

Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI

University of Massachusetts, Worcester

NCT05671874

ACTIVE NOT RECRUITING NA 15 participants

An EFS to Evaluate the CGuard Prime™ Carotid Stent in Acute Ischemic Stroke

Jacobs institute

NCT06447116

COMPLETED Phase 3 1,151 participants

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial

University of Virginia

NCT01369069

COMPLETED Phase 3 1,000 participants

Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)

PhotoThera

NCT01120301

COMPLETED Phase 3 514 participants

Multi-arm Optimization of Stroke Thrombolysis

Washington University School of Medicine

NCT03735979

COMPLETED NA 216 participants

THUNDER: Acute Ischemic Stroke Study with the Penumbra System® Including Thunderbolt™ Aspiration Tubing

Penumbra

NCT05437055

COMPLETED NA 196 participants

Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial

Medtronic Neurovascular Clinical Affairs

NCT01657461

COMPLETED NA 146 participants

Imaging Guided Patient Selection for Interventional Revascularization Therapy

Penumbra

NCT00963989

COMPLETED Phase 1 106 participants

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke

Daiichi Sankyo

NCT02586233

COMPLETED NA 60 participants

C-arm Cone Beam CT Perfusion Guided Cerebrovascular Interventions

University of Wisconsin, Madison

NCT03232151

COMPLETED Phase 1 30 participants

Caffeinol Hypothermia Protocol

The University of Texas Health Science Center, Houston

NCT00299416

COMPLETED Phase 2 24 participants

A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS

Lumosa Therapeutics Co.

NCT04091945

COMPLETED Phase 2

A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)

Astellas Pharma

NCT00044057

Phase Distribution

PhaseTrial count
Early Phase 1 2
Phase 2 7
Phase 3 5
Phase 4 1

Top Sponsors

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Acute Ischemic Stroke Trial Landscape

ClinicalTrials.gov lists 27 US studies indexed under Acute Ischemic Stroke, and 12 of those are currently open to recruitment — roughly 44% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Acute Ischemic Stroke shows 6 late-stage studies (Phase 3 and Phase 4 combined) alongside 9 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Acute Ischemic Stroke is led by Lumosa Therapeutics Co. with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 27 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Acute Ischemic Stroke?

PlainTrial tracks 27 US clinical trials for Acute Ischemic Stroke, of which 12 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Acute Ischemic Stroke?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →